COVID-19 Vaccine: Moderna Gets $483M Funding Boost from BARDA
By Rajaneesh K. Gopinath, Ph.D. Moderna, the Cambridge-based, clinical-stage biotech, specializes in mRNA therapeutics and vaccines. It was the first to attempt human testing of a potential COVID-19 vaccine in …
Read More